Why the study?
Empirical data on the superiority of opioid-free anesthesia compared to standard anesthesia with multimodal analgesia are contradictory, potential benefits are questioned, and little is known about long-term sequelae.
Does opioid-free anesthesia improve outcomes compared to standard anesthesia in obese patients undergoing bariatric surgery?
Does opioid-free anesthesia improve outcomes compared to standard anesthesia in obese patients undergoing bariatric surgery?
The superiority of opioid-free anesthesia over standard anesthesia with multimodal analgesia in bariatric surgery remains controversial based on current contradictory evidence.
This is the authors' abstract. We don't add key points for this paper.
Opioid-free anesthesia (OFA) is a heterogeneous group of general anesthesia techniques in which the intraoperative use of opioids is eliminated. This strategy aims to decrease the risk of complications and improve the patient's safety and comfort. Such potential advantages are particularly beneficial for selected groups of patients, among them obese patients undergoing laparoscopic bariatric surgery. Opioids have been traditionally used as an element of balanced anesthesia, and replacing them requires using a combination of coanalgesics and various types of local and regional anesthesia, which also have their side effects, limitations, and potential disadvantages. Moreover, despite the growing amount of evidence, the empirical data on the superiority of OFA compared to standard anesthesia with multimodal analgesia are contradictory, and potential benefits in many studies are being questioned. Additionally, little is known about the long-term sequelae of such a strategy. Considering the above-mentioned issues, this study aims to present the potential benefits, risks, and difficulties of implementing OFA in bariatric surgery, considering the current state of knowledge and literature.
Answers are grounded in this paper and cite their sources.
Opioid-free anesthesia should not replace standard multimodal regimens in bariatric surgery yet; leaves open the need for conclusive randomized trials.
No takes yet. Share an insight, caveat, or question.
Mieszczański et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: